Department of Medicine

Division of Hematology and Oncology

James W. Lynch, Jr, MD Professor of Medicine Division of Hematology/Oncology Section Chief, Hematology/Oncology VAMC 1600 SW Archer Road/Box 100278 Gainesville, FL 32610-0278 (352) 273-7761/FAX (352) 392-8530

Dr. Lynch’s training has taken him to the University of Virginia, Eastern Virginia Medical School, the University of Florida, and the National Cancer Institute’s Clinical Oncology Program, and now serves as a Professor of Medicine and Section Chief for Hematology/Oncology at the VAMC.

Dr. Lynch a course director, an educational innovator and has received many teaching awards throughout his career including clinical teacher of the year on multiple occasions, the Hippocratic award in 1995 and 2003 and 2008. He has been inducted into numerous societies including the Chapman Humanism Society, The Society of Teaching Scholars for the college of medicine and finally in 2006, he was named a Distinguished Teaching Scholar for the University of Florida. For 13 years he served as the program director for the hematology/oncology fellowship program.

Dr. Lynch’s is recognized as national leader in diagnosis and treatment of lymphomas where he maintains an active clinical practice. He has published over 100 articles, chapters and abstracts and continues an active research program focusing on the diagnosis, prognosis and developing novel therapies for patients with Non-Hodgkin’s lymphomas and Hodgkin’s disease.

Training:

Academic Interests:

Medical Education Hodgkin’s Disease and Non-Hodgkin’s Lymphoma

Clinical Interests:

Hodgkin’s Disease and Non-Hodgkin’s Lymphoma

Research Interests:

Experimental Therapeutics and prognostic factors for Hodgkin’s Disease and Non-Hodgkin’s Lymphoma

Representative Publications:

• Lynch JW. A Piece of My Mind: Regaining Compassion, JAMA, May 13, 1998, 279(18):1422
• Hagler KT, Lynch Jr, JW. Comparison Between United States And Europe Of Enrollment Of Adult Patients In Published Lymphoma Clinical Trials; Florida Joint Cancer Conference Fellows Forum; February 2005
• Chera BS, Olivier K, Morris C, Lynch JW, Mendenhall NP; Long term outcomes in Lymphocyte Predominant Hodgkin’s Disease: American Society of Therapeutic Radiology, 2006.
• Patel MR, Weidner M, Walden E, Lynch JW, George TJ; Retrospective Review of Stage III Non-Small Cell Lung Cancer Patients Treated with Carboplatin/Paclitaxel plus Radiotherapy followed by Docetaxel. ASCO 2007
• Nair J, Liu H and Lynch JW; A Case of POEMS Syndrome with Leukopenia: ACP meeting May 07.
• DM Cardona, Y Li, KJ Walsh, BA Gray, JW Lynch, RC Braylan and SZ Al-Quran. Dept of Pathology, University of Florida, Gainesville, FL, United States and Division of Hematology/Oncology, Dept of Medicine, University of Florida, Gainesville, FL, United States. Tumor-Associated S-Phase Fraction Correlates with the Presence of c-MYC Translocation in Aggressive CD10-Expressing B-Cell Lymphomas and may predict their Clinical Course. Submitted to USCAP pathology meeting (http://www.USCAP.org/)
• Jennifer R. Duff and James W. Lynch .Long Term Follow-Up and Retreatment of Patients with Low-Grade Lymphoproliferative Disorders (LPD) after 1 Year of Phamacokinetic (PK) Based Maintenance Therapy with Rituximab. Blood (ASH Annual Meeting Abstracts), Nov 2007; 110: 4479.
• Katherine Walsh MD, James W. Lynch MD, Kenneth Olivier MD: False Positive PET Scans: Review Of a Single Institution Experience In Patients With Lymphoma: Division of Hematology/Oncology; Department of Medicine and the Department of Radiation Oncology. University of Florida, Gainesville, FL; Department of Medicine Research Day. June 2008